Westport Fuel Systems Azioni (NASDAQ: WPRT)

Ultime notizie per Westport Fuel Systems (NASDAQ:WPRT) Azioni

Westport Fuel Systems

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing, and capital allocation.

Westport Fuel Systems Inc - Common Shares

Westport Fuel Systems Inc

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Buy and maintains $22 price target.

News

Price Target

Reiteration

Analyst Ratings

WPRT

HC Wainwright & Co. Reiterates Buy on Westport Fuel Systems, Maintains $22 Price Target

RBC Capital analyst Chris Dendrinos reiterates Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Sector Perform and maintains $8 price target.

RBC Capital Reiterates Sector Perform on Westport Fuel Systems, Maintains $8 Price Target

Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.37) by 40.54 percent. The company reported quarterly sales of $66.251 million which missed the analyst consensus estimate of $66.447 million by 0.29 percent. This is a 14.39 percent decrease over sales of $77.391 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Westport Fuel Systems Q3 2024 GAAP EPS $(0.22) Beats $(0.37) Estimate, Sales $66.251M Miss $66.447M Estimate

ABOS

ABSI

ACNT

ACTG

AENT

AGEN

AIOT

AIRG

ALIT

ALTG

AMBC

AMPS

AMTX

APEI

AREB

ARIS

ARMN

ATRA

AUTL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXSM

AZTA

BHIL

BLDE

BLFS

BLTE

The Beachbody Company, Inc. Class A Common Stock

BODI

BRTX

BTMD

BTTR

BWAY

BXSL

BZFD

CAMT

CART

CATX

CAVA

CBAT

CBLL

CCLD

CGEN

CHGG

CHMI

CLSD

CNNE

CRNX

CRON

CRVS

CRWS

CVAC

CXAI

DAVA

DAVE

DRCT

DYAI

EARN

EGAN

ELMD

ETON

EVCM

EVGO

EYEN

FENG

FGEN

FIHL

FLNG

FOUR

FTCI

GENI

GENK

GMGI

GOVX

GRAL

GRDN

GROV

GRPN

GRVY

Earnings Scheduled For November 12, 2024

RBC Capital analyst Chris Dendrinos maintains Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Sector Perform and lowers the price target from $9 to $8.

TSX:WPRT

RBC Capital Maintains Sector Perform on Westport Fuel Systems, Lowers Price Target to $8

Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.53) by 39.62 percent. The company reported quarterly sales of $83.386 million which missed the analyst consensus estimate of $86.924 million by 4.07 percent. This is a 1.92 percent decrease over sales of $85.022 million the same period last year.

Westport Fuel Systems Q2 2024 Adj. EPS $(0.32) Beats $(0.53) Estimate, Sales $83.386M Miss $86.924M Estimate

HC Wainwright &amp; Co. analyst Amit Dayal maintains Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Buy and lowers the price target from $30 to $22.

HC Wainwright & Co. Maintains Buy on Westport Fuel Systems, Lowers Price Target to $22

Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.55) by 43.64 percent. This is a 31.67 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $77.574 million which missed the analyst consensus estimate of $84.740 million by 8.46 percent. This is a 5.67 percent decrease over sales of $82.240 million the same period last year.

Westport Fuel Systems Q1 2024 GAAP EPS $(0.79) Misses $(0.55) Estimate, Sales $77.574M Miss $84.740M Estimate

RBC Capital analyst Chris Dendrinos maintains Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Sector Perform and lowers the price target from $10 to $9.

RBC Capital Maintains Sector Perform on Westport Fuel Systems, Lowers Price Target to $9

Oppenheimer analyst Colin Rusch maintains Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Outperform and maintains $19 price target.

Oppenheimer Maintains Outperform on Westport Fuel Systems, Maintains $19 Price Target

HC Wainwright &amp; Co. analyst Amit Dayal maintains Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Buy and maintains $30 price target.

HC Wainwright & Co. Maintains Buy on Westport Fuel Systems, Maintains $30 Price Target

Shares of Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) fell sharply during Tuesday&rsquo;s session after posting a wider-than-expected fourth-quarter loss.
Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.
Westport Fuel Systems shares dipped 9.9% to $6.52 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Stoke Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stok#NASDAQ">STOK</a>) shares gained 72.6% to $11.24 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) climbed 65% to $0.0581 after the company reported a year-over-year increase in fourth-quarter financial results.</li>
<li>OpGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opgn#NASDAQ">OPGN</a>) shares climbed 48.2% to $0.7039 after the company entered into a securities purchase agreement with a private investor, David Lazar, to acquire 3 million shares of Series E Convertible Preferred Stock at $1.00 per share for aggregate gross proceeds of $3.0 million.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 43.2% to $3.1501. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease.</li>
<li>Praxis Precision Medicines Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prax#NASDAQ">PRAX</a>) gained 31.9% to $66.63 after the company reported results from a Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR.</li>
<li>Nuvation Bio Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nuvb#NYSE">NUVB</a>) climbed 24.4% to $2.80 after BTIG upgraded the stock from Neutral to Buy.</li>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) shares gained 24.3% to $2.40 after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI.</li>
<li>Viking Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) shares climbed 23.3% to $85.29 after the company announced results from its Phase 1 multiple ascending dose clinical trial of an oral tablet formulation of VK2735.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) gained 21.3% to $15.10 after the company and McDonald&#39;s expanded their partnership, with Krispy Kreme to provide donuts at McDonald&#39;s locations nationwide.</li>
<li>Journey Medical Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) gained 19.9% to $3.50.</li>
<li>Akso Health Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ahg#NASDAQ">AHG</a>) climbed 17.5% to $1.21.</li>
<li>9F Inc &ndash; ADR (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfu#NASDAQ">JFU</a>) gained 17% to $3.50.</li>
<li>Invivyd, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivvd#NASDAQ">IVVD</a>) gained 17% to $3.78. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.</li>
<li>Sunnova Energy International Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) shares gained 16.4% to $6.28 after the company announced that it will be the sole provider of solar and battery storage services in The Home Depot stores across the United States and its territories.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwav#NASDAQ">GWAV</a>) climbed 16.3% to $0.18 after surging 24% on Monday. Greenwave Technology Solutions 13G filing showed Joseph Reda reported a 9.119% stake in the co as of March 22, 2024.</li>
<li>Reddit Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rddt#NYSE">RDDT</a>) climbed 15.8% to $69.26 amid post-IPO volatility.</li>
<li>Canopy Growth Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) shares gained 15.6% to $7.17.</li>
<li>Qurate Retail Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrteb#NASDAQ">QRTEB</a>) climbed 13.7% to $4.40.</li>
<li>Natural Grocers by Vitamin Cottage Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ngvc#NYSE">NGVC</a>) climbed 13.4% to $19.25.</li>
<li>60 Degrees Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtp#NASDAQ">SXTP</a>) shares rose 9.8% to $0.2660 after dipping 10% on Monday.</li>
<li>Seagate Technology Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stx#NASDAQ">STX</a>) gained 9.2% to $96.33 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $73 to $115.</li>
<li>McCormick &amp; Company Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkc#NYSE">MKC</a>) climbed 9% to $76.24 after the company reported better-than-expected first-quarter financial results.</li>
<li>IHS Holding Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ihs#NYSE">IHS</a>) climbed 7.6% to $3.74.</li>
<li>Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) gained 5.8% to $182.65 amid reports suggest Italy has approached the company about electric truck production.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quhuo Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qh#NASDAQ">QH</a>) dipped 68.5% to $0.40.</li>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) fell 51.8% to $0.48 after declining around 3% on Monday.</li>
<li>Cardlytics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) dipped 40.4% to $12.06 after the company announced a $150 million proposed convertible senior notes offering.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) fell 39.3% to $1.00 after the company priced its 2 million share offering at $1 per share.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares tumbled 27.6% to $0.037 after jumping around 30% on Monday.</li>
<li>Professional Diversity Network Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipdn#NASDAQ">IPDN</a>) fell 27.2% to $1.82.</li>
<li>Canoo Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goev#NASDAQ">GOEV</a>) shares fell 21.4% to $3.30.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) fell 20.2% to $6.68 after the company reported fourth-quarter results, disclosed equity raise and new CEO for its international business.</li>
<li>Equillium Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eq#NASDAQ">EQ</a>) shares declined 20.1% to $1.95 following fourth-quarter results.</li>
<li>BYND Cannasoft Enterprises (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) shares fell 17.9% to $1.61.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) shares declined 17.9% to $14.78.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares dropped 17.8% to $2.08 after the company reported downbeat fourth-quarter results.</li>
<li>Etao International (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etao#NASDAQ">ETAO</a>) shares fell 14.7% to $4.35.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) fell 14.4% to $1.24 after posting fourth-quarter results.</li>
<li>Akebia Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akba#NASDAQ">AKBA</a>) shares dipped 9.5% to $2.00.</li>
<li>Graphjet Technology (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gti#NASDAQ">GTI</a>) fell 9.3% to $7.26.</li>
<li>Monte Rosa Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glue#NASDAQ">GLUE</a>) dipped 8.4% to $7.75.</li>
<li>Consol Energy Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ceix#NYSE">CEIX</a>) declined 8.1% to $79.36.</li>
<li>RH (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) fell 4% to $276.00. Telsey Advisory Group analyst Joseph Feldman reiterated RH with a Market Perform and maintained a $285 price target.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37934560/ethereum-surpasses-3-600-dogwifhat-emerges-as-top-gainer"> Ethereum Surpasses $3,600; dogwifhat Emerges As Top Gainer</a>

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AKBA

APCX

BCAN

CDLX

CEIX

CHEK

CISS

DADA

DERM

DNUT

EGOX

ETAO

GLUE

GOEV

GWAV

IPDN

IVVD

MESO

MRNO

NBSE

NGVC

NOVA

NUVB

OPGN

PRAX

QRTEB

RDDT

STOK

SXTP

TIVC

TSLA

VKTX

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Stoke Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stok#NASDAQ">STOK</a>) rose sharply in today&rsquo;s pre-market trading after the company announced Phase 1/2a data supporting the potential for <a href="https://www.benzinga.com/general/biotech/24/03/37923355/stoke-therapeutics-stock-rockets-on-phase-12a-data-heres-why">STK-001 in Dravet syndrome</a>.
Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) shares gained 38.3% to $2.67 in pre-market trading. Nobul AI Corp entered into business combination agreement with Check-Cap.</li>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) rose 35.2% to $0.0476 in pre-market trading. C3is is expected to release its fourth quarter financial results before the opening bell on March 26, 2024.</li>
<li>OpGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opgn#NASDAQ">OPGN</a>) gained 30.4% to $0.6196 in pre-market trading after the company announced David Lazar will invest $3 million in preferred stock and take over as CEO.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 23.2% to $2.71 in pre-market trading. Mesoblast was notified by the U.S. FDA that available clinical data from Phase 3 trial appear sufficient to support BLA submission for Remestemcel-L in children with steroid-refractory acute graft versus host disease.</li>
<li>Intelligent Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intj#NASDAQ">INTJ</a>) shares rose 19.7% to $2.31 in pre-market trading after dipping around 9% on Monday.</li>
<li>Krispy Kreme, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnut#NASDAQ">DNUT</a>) gained 16.3% to $14.48 in pre-market trading. McDonald&#39;s USA and Krispy Kreme announced expanded national partnership.</li>
<li>60 Degrees Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtp#NASDAQ">SXTP</a>) shares rose 15.6% to $0.28 in pre-market trading after dipping 10% on Monday.</li>
<li>Invivyd, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivvd#NASDAQ">IVVD</a>) gained 13% to $3.65 in pre-market trading. Morgan Stanley analyst Maxwell Skor upgraded Invivyd from Equal-Weight to Overweight and raised the price target from $4 to $10.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwav#NASDAQ">GWAV</a>) climbed 10.3% to $0.1661 in pre-market trading after surging 24% on Monday. Greenwave Technology Solutions 13G filing showed Joseph Reda reported a 9.119% stake in the co as of March 22, 2024.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>NeuBase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbse#NASDAQ">NBSE</a>) dipped 54.5% to $0.4497 in pre-market trading after declining around 3% on Monday.</li>
<li>AppTech Payments Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apcx#NASDAQ">APCX</a>) declined 35.8% to $1.06 in pre-market trading as the company disclosed a proposed underwritten public offering of common stock.</li>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) fell 20% to $1.16 pre-market trading after posting fourth-quarter results.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) fell 12.5% to $0.3530 pre-market trading after the company posted downbeat results for its fourth quarter on Monday. The company also said it sees first-quarter overall revenues of $42 million to $44 million.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) shares fell 12.2% to $0.7285 in pre-market trading. Vivakor shares fell around 7% on Monday after the company announced that it signed a definitive Membership Interest Purchase Agreement to acquire Endeavor Entities.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) shares tumbled 11.6% to $0.0450 in pre-market trading after jumping around 30% on Monday.</li>
<li>Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) fell 10.5% to $6.47 in pre-market trading after posting a wider-than-expected fourth-quarter loss.</li>
<li>Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) fell 10.3% to $1.31 in pre-market trading.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) shares dropped 9.1% to $2.30 in pre-market trading after the company reported downbeat fourth-quarter results.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) fell 6.1% to $7.86 in pre-market trading&nbsp;following fourth-quarter results.&nbsp;GDS named Jamie Khoo as CEO of GDS International.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37908125/cramer-isnt-knocking-this-pharma-firm-anymore-as-a-matter-of-fact-im-going-in"> Cramer Isn&#39;t &#39;Knocking&#39; This Pharma Firm Anymore: &#39;As A Matter Of Fact, I&#39;m Going In&#39;</a>

Pre-Market Outlook

BREA

INTJ

VIVK

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.51) by 58.82 percent. This is a 19 percent increase over losses of $(1.00) per share from the same period last year. The company reported quarterly sales of $87.20 million which beat the analyst consensus estimate of $86.49 million by 0.82 percent. This is a 11.79 percent increase over sales of $78.00 million the same period last year.

Westport Fuel Systems Q4 EPS $(0.81) Misses $(0.51) Estimate, Sales $87.20M Beat $86.49M Estimate

Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) reported its Q4 earnings results on Monday, March 25, 2024 at 05:00 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Westport Fuel Systems missed estimated earnings by -59.0%, reporting an EPS of $-0.81 versus an estimate of $-0.51.
Revenue was up $9.20 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.06 which was followed by a 1.0% increase in the share price the next day.
Here's a look at Westport Fuel Systems's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.62</td>
<td>-0.60</td>
<td>-0.8</td>
<td>-0.6</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.68</td>
<td>-0.77</td>
<td>-0.6</td>
<td>-1</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>77.06M</td>
<td>82.65M</td>
<td>77.96M</td>
<td>74.45M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>77.39M</td>
<td>85.02M</td>
<td>82.24M</td>
<td>78.00M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Westport Fuel Systems <a href="https://www.benzinga.com/quote/WPRT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Westport Fuel Systems: Q4 Earnings Insights

<h3>Companies Reporting Before The Bell</h3>
&bull; Bitcoin Depot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTM#NASDAQ">BTM</a>) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
&bull; Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) is likely to report quarterly loss at $0.09 per share on revenue of $2.23 million.
&bull; Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) is likely to report earnings for its fourth quarter.
&bull; LightInTheBox Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITB#NYSE">LITB</a>) is projected to report earnings for its fourth quarter.
&bull; D-MARKET Electronic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPS#NASDAQ">HEPS</a>) is estimated to report earnings for its fourth quarter.
&bull; Viomi Technology Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIOT#NASDAQ">VIOT</a>) is expected to report earnings for its Fiscal Year 2023.
<h3>Companies Reporting After The Bell</h3>
&bull; GreenTree Hospitality Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHG#NYSE">GHG</a>) is expected to report earnings for its Fiscal Year 2023.
&bull; Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) is expected to report quarterly loss at $0.10 per share on revenue of $10.72 million.
&bull; TMC Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) is estimated to report earnings for its fourth quarter.
&bull; Dada Nexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DADA#NASDAQ">DADA</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $432.74 million.
&bull; VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) is expected to report quarterly loss at $0.11 per share on revenue of $450 thousand.
&bull; Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) is expected to report earnings for its fourth quarter.
&bull; Lucid Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCD#NASDAQ">LUCD</a>) is expected to report quarterly loss at $0.26 per share on revenue of $1.05 million.
&bull; BuzzFeed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZFD#NASDAQ">BZFD</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $104.60 million.
&bull; Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) is likely to report quarterly loss at $0.13 per share on revenue of $16.50 million.
&bull; Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) is expected to report earnings for its fourth quarter.
&bull; Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) is likely to report quarterly loss at $0.51 per share on revenue of $86.49 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

HEPS

LITB

LUCD

REKR

SMTI

SYRA

TOVX

VIOT

VNRX

Earnings Scheduled For March 25, 2024

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) to report quarterly earnings at 9 cents per share on revenue of $432.74 million after the closing bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Dada Nexus shares gained 0.9% to $2.33 in after-hours trading.
Salarius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrx#NASDAQ">SLRX</a>) posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share. Salarius Pharmaceuticals shares jumped 50.6% to $0.9335 in the after-hours trading session.
LightInTheBox Holding Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/litb#NYSE">LITB</a>) is expected to release its unaudited financial results for the fourth quarter before the opening bell on Monday. LightInTheBox shares gained 4.9% to close at $0.7929 on Friday.
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
Masimo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/masi#NASDAQ">MASI</a>) shares rose sharply during Friday&rsquo;s after-hours trading session after the company announced it has authorized management to evaluate a proposed separation of its consumer business. The company also reaffirmed its first-quarter and FY24 guidance. Masimo shares jumped 13.9% to $153.65 in the after-hours trading session.
Analysts expect Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>) to post a quarterly loss at 51 cents per share on revenue of $86.49 million after the closing bell. Westport Fuel shares fell 7.1% to $5.85 in the after-hours trading session.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37889794/vista-gold-and-2-other-stocks-under-2-insiders-are-buying"> Vista Gold And 2 Other Stocks Under $2 Insiders Are Buying </a>
&nbsp;

MASI

SLRX

Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index remained in the &quot;Greed&quot; zone on Friday.
The Dow Jones index settled lower on Friday but recorded its best week of the year. All three major indices notched gains last week, with the S&amp;P 500 gaining about 2.3%, and the Dow adding approximately 2% to record its best week since December.
Shares of Lululemon Athletica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>) fell around 16% during Friday&rsquo;s session after releasing fourth-quarter results. Nike Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nke#NYSE">NKE</a>) shares fell around 7% on Friday after the company reported results for its third quarter. FedEx Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdx#NYSE">FDX</a>) shares gained over 7% on Friday after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program on Thursday.
On the economic data front, the total number of active U.S. oil rigs fell by 1 rig this week, Baker Hughes Inc. reported.
Most sectors on the S&amp;P 500 closed on a negative note, with real estate, financial and consumer discretionary stocks recording the biggest losses on Friday. However, information technology and communication services bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 305 points to 39,475.90 on Friday. The S&amp;P 500 fell 0.14% at 5,234.18, while the Nasdaq Composite climbed 0.16% at 16,428.82 during Friday&rsquo;s session.
Investors are awaiting earnings results from Westport Fuel Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wprt#NASDAQ">WPRT</a>), BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) and Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) today.
At a current reading of 71.8, the index remained in the &quot;Greed&quot; zone on Friday, versus a prior reading of 74.3.
What Is The CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: <a href="https://www.benzinga.com/news/24/03/37889754/top-5-consumer-stocks-that-may-crash-this-month"> Top 5 Consumer Stocks That May Crash This Month</a>

LULU

Investor Sentiment Falls, But Dow Records Strongest Week Since December

Westport announces at-the-market equity offering program

Westport Fuel Systems (TSE:WPRT) has released an update. Westport Fuel Systems Inc. has launched an at-the-market equity offering program to sell u...

Westport Launches $35M Equity Offering for Growth

Craig-Hallum analyst Eric Stine maintained a Buy rating on Westport Fuel Systems (WPRT – Research Report) today. The company's shares closed last F...

Westport Fuel Systems (WPRT) Receives a Buy from Craig-Hallum

Westport Fuel Systems GAAP EPS of -$0.22 beats by $0.15, revenue of $66.2M misses by $0.25M

Reports Q3 revenue $66.2M, consensus $66.45M. CEO Dan Sceli said, "Westport (WPRT) delivered solid results in the third quarter of 2024. Although r...

Westport reports Q3 EPS (22c), consensus (37c)

Westport Fuel Systems (TSE:WPRT) has released an update. Westport Fuel Systems has reported a 14% revenue decline for Q3 2024, mainly due to transi...

Westport Fuel Systems Reports Q3 Revenue and Strategy

Westport Fuel Systems Inc. (WPRT) Q3 2024 Earnings Call Transcript

TD Cowen analyst Jeff Osborne maintained a Hold rating on Westport Fuel Systems (WPRT – Research Report) today and set a price target of $6.00. Jef...

Westport Fuel Systems: Hold Rating Amid Revenue Transition and Cost Management Improvements, Yet Challenges Persist

RBC Capital analyst Chris Dendrinos assigned a Hold rating to Westport Fuel Systems (WPRT – Research Report) yesterday and set a price target of $8...

RBC Capital Issues a Hold Rating on Westport Fuel Systems (WPRT)

Amit Dayal, an analyst from H.C. Wainwright, maintained the Buy rating on Westport Fuel Systems (WPRT – Research Report). The associated price targ...

Positive Market Outlook and Strategic Growth Potential for Westport Fuel Systems Justifies Buy Rating

Commodities

Westport Publishes Annual General Meeting Results

Comments

Westport Fuel Systems

Notizie

Ultime notizie per Westport Fuel Systems (NASDAQ:WPRT) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO